KCNH2 and torsades de pointes: As previously discussed, the common mechanism by which the majority of drugs produce QT prolongation and thus increased risk of TdP is through IKr blockade by Kv11.1 inhibition, as well as possible inhibition of Kv11.1 channel trafficking [40].